187 related articles for article (PubMed ID: 20599921)
1. Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity.
Zhu J; Zhang J; Xiang D; Zhang Z; Zhang L; Wu M; Zhu S; Zhang R; Han W
Eur J Pharmacol; 2010 Sep; 643(2-3):247-53. PubMed ID: 20599921
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity.
Zhu J; Zhang J; Zhang L; Du R; Xiang D; Wu M; Zhang R; Han W
Biomed Pharmacother; 2011 Oct; 65(7):481-5. PubMed ID: 22000485
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice.
Shen J; Gao J; Zhang J; Xiang D; Wang X; Qian L; Shen J; Yang L; Zhu S; Wu M; Yu Y; Han W; Wang X
Biomed Pharmacother; 2012 Mar; 66(2):83-8. PubMed ID: 22281291
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity.
Fouad AA; Yacoubi MT
Arch Pharm Res; 2011 May; 34(5):821-8. PubMed ID: 21656368
[TBL] [Abstract][Full Text] [Related]
5. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo.
Qian L; Xiang D; Zhang J; Zhu S; Gao J; Wang X; Gao J; Zhang Y; Shen J; Yu Y; Han W; Wu M
Biomed Pharmacother; 2013 Mar; 67(2):108-15. PubMed ID: 23433850
[TBL] [Abstract][Full Text] [Related]
7. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
[TBL] [Abstract][Full Text] [Related]
8. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
9. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
10. Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis.
Wang X; Gao J; Qian L; Gao J; Zhu S; Wu M; Zhang Y; Guan W; Ye H; Yu Y; Han W
Anticancer Drugs; 2015 Jan; 26(1):35-45. PubMed ID: 24999837
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.
Loddick SA; Rothwell NJ
J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous mast cell degranulation in rats receiving injections of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) and/or its vehicle: possible clinical implications.
Bendele A; Colloton M; Vrkljan M; Morris J; Sabados K
J Lab Clin Med; 1995 Apr; 125(4):493-500. PubMed ID: 7706905
[TBL] [Abstract][Full Text] [Related]
15. Effect of stimulation and antagonism of interleukin-1 signaling on preterm delivery in mice.
Yoshimura K; Hirsch E
J Soc Gynecol Investig; 2005 Oct; 12(7):533-8. PubMed ID: 16202930
[TBL] [Abstract][Full Text] [Related]
16. The in vivo effect of recombinant human interleukin-1 receptor antagonist on spleen colony forming cells after radiation induced myelosuppression.
Milenkovíc P; Ivanovíc Z; Stosić-Grujicić S
Eur Cytokine Netw; 1995; 6(3):177-80. PubMed ID: 8589274
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.
Sanderson KL; Raghupathi R; Saatman KE; Martin D; Miller G; McIntosh TK
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1118-25. PubMed ID: 10532636
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: role of oxidative stress and apoptosis.
Soni H; Pandya G; Patel P; Acharya A; Jain M; Mehta AA
Toxicol Appl Pharmacol; 2011 May; 253(1):70-80. PubMed ID: 21443895
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection.
Abd-Allah AR; Al-Majed AA; Mostafa AM; Al-Shabanah OA; Din AG; Nagi MN
J Biochem Mol Toxicol; 2002; 16(5):254-9. PubMed ID: 12439867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
